SCHEMBL5034346

SCHEMBL5034346

CCN(CC)c1cccc(Oc2cc(C#N)c3[nH]cc(C4CCN(S(=O)(=O)CC)CC4)c3c2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 12/20 0.44
CHUK O15111 3/20 0.44
AURKA O14965 1/20 0.40
FLT3 P36888 1/20 0.40
CSNK1E P49674 1/20 0.40
BTK Q06187 1/20 0.40
CYP2D6 P10635 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
PGR P06401 1/20 0.34
CYP2C9 P11712 1/20 0.34
GFER P55789 1/20 0.33
SLC6A4 P31645 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
THRB P10828 1/20 0.33
ALOX15 P16050 1/20 0.33
RECQL P46063 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4595720 0.85 IKBKB (0.45) IKBKBCHUKAURKAFLT3CSNK1E
SCHEMBL4590382 0.85 IKBKB (0.61) IKBKBCHUKAURKAFLT3CSNK1E
SCHEMBL4590044 0.84 IKBKB (0.46) IKBKBCHUKAURKAFLT3CSNK1E
SCHEMBL4590194 0.84 IKBKB (0.46) IKBKBCHUKAURKAFLT3CSNK1E
SCHEMBL5035290 0.78 IKBKB (0.52) IKBKBCHUKAURKAFLT3CSNK1E
SCHEMBL5035303 0.77 CYP1A2 (0.32) CYP2D6CYP1A2CYP3A4CYP2C19GFER
SCHEMBL14528352 0.76 IKBKB (0.52) IKBKBCHUKAURKAFLT3CSNK1E
SCHEMBL5040242 0.76 IKBKB (0.49) IKBKBCHUKAURKAFLT3CSNK1E
SCHEMBL3795295 0.69 IKBKB (0.72) IKBKBCHUKAURKAFLT3CSNK1E
SCHEMBL4589931 0.69 IKBKB (0.62) IKBKBCHUKAURKAFLT3CSNK1E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269291-A1 Chemical Compounds GLAXOSMITHKLINE LLC 2008-10-30 US disclosed
US-20080269291-A1 Chemical Compounds GLAXOSMITHKLINE LLC 2008-10-30 US disclosed
US-20080269291-A1 Chemical Compounds GLAXOSMITHKLINE LLC 2008-10-30 US disclosed
WO-2007062318-A2 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2007-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269291-A1 Chemical Compounds IDO2, IKBKG, NFKBIA IKBKB 8/4885CHUK 28/4885AURKA 1253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.